CCR5 Antagonist TD-0680 Uses a Novel Mechanism for Enhanced Potency against HIV-1 Entry, Cell-mediated Infection, and a Resistant Variant
Yuanxi Kang, Zhiwei Chen(Fujian Medical University), Jenny Ng(University of Hong Kong), Terrence Chi‐Kong Lau(Tung Wah College), Zhiwei Wu(Ningxia University), Sai Kam Li(City University of Hong Kong), Haibo Wang(The Third People's Hospital of Dalian City), Li Chen(Nanjing General Hospital of Nanjing Military Command), Li Liu(Hangzhou Hospital of Traditional Chinese Medicine), Xiaofan Lu, Jianguo Liang(Chinese University of Hong Kong), Zhiwu Tan(Anhui Agricultural University), Allen Ka Loon Cheung(Hong Kong Baptist University), Bo‐Jian Zheng(University of Hong Kong), Ben Li(St. Michael's Hospital)
Cited by 17
Related Papers
Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000
|The Lancet|2012|4k
Global, regional, and national causes of under-5 mortality in 2000–15: an updated systematic analysis with implications for the Sustainable Development Goals
|The Lancet|2016|3.6k
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
|The Lancet Infectious Diseases|2020|3.4k